{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:58:39Z","timestamp":1772265519785,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fapemig\/PPSUS","award":["APQ-03535\/13"],"award-info":[{"award-number":["APQ-03535\/13"]}]},{"name":"Fapemig\/Pronex","award":["APQ-00704-14"],"award-info":[{"award-number":["APQ-00704-14"]}]},{"name":"CNPq\/INCT-DT","award":["465229\/2014-0"],"award-info":[{"award-number":["465229\/2014-0"]}]},{"DOI":"10.13039\/501100004901","name":"Fapemig","doi-asserted-by":"publisher","award":["RED-00140-16"],"award-info":[{"award-number":["RED-00140-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jconrel.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T02:33:29Z","timestamp":1518057209000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The use of gold nanorods as a new vaccine platform against schistosomiasis"],"prefix":"10.1016","volume":"275","author":[{"given":"Natan R.G.","family":"Assis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson J.","family":"Caires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara C.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suellen B.","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio S.","family":"Mambelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio V.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds O.","family":"Ladeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-5577","authenticated-orcid":false,"given":"Sergio C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.02.004_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13071-016-1799-4","article-title":"Schistosomiasis vaccines: where do we stand?","volume":"9","author":"Tebeje","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00436-001-0587-y","article-title":"Chemotherapeutic approaches to trematodes (except schistosomes) and cestodes: current level of knowledge and outlook","volume":"88","author":"Harder","year":"2002","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0020","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"Gryseels","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1745-7270.2007.00340.x","article-title":"Characterization of a partially protective B-cell epitope within the 62\u202fkDa antigen of Schistosoma japonicum","volume":"39","author":"Zhang","year":"2007","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2018.02.004_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0074-02761998000700013","article-title":"Schistosomiasis vaccine development: progress and prospects","volume":"93","author":"Bergquist","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0264-410X(97)00071-6","article-title":"Human schistosomiasis: potential long-term consequences of vaccination programmes","volume":"15","author":"Chan","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrmicro801","article-title":"Schistosomiasis","volume":"2","author":"Chitsulo","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000308","article-title":"Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection","volume":"2","author":"Cardoso","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0055","article-title":"Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates","volume":"2011","author":"Pinheiro","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.2006.03081.x","article-title":"Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies","volume":"144","author":"Cardoso","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0065","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125075","article-title":"DNA vaccine encoding the chimeric form of schistosoma mansoni Sm-TSP2 and Sm29 confers partial protection against challenge infection","volume":"10","author":"Goncalves de Assis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/pim.12118","article-title":"A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice","volume":"36","author":"Pinheiro","year":"2014","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0080","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1039\/C1CS15237H","article-title":"The golden age: gold nanoparticles for biomedicine","volume":"41","author":"Dreaden","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0085","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1002\/adma.200802789","article-title":"Gold nanorods: from synthesis and properties to biological and biomedical applications","volume":"21","author":"Huang","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0090","doi-asserted-by":"crossref","first-page":"295102","DOI":"10.1088\/0957-4484\/24\/29\/295102","article-title":"Gold nanorod vaccine for respiratory syncytial virus","volume":"24","author":"Stone","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0095","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-6-1","article-title":"Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis","volume":"6","author":"Cardoso","year":"2007","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0105","first-page":"609","article-title":"Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis","volume":"5","author":"Cardoso","year":"2006","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0110","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1038\/srep11398","article-title":"Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo","volume":"5","author":"Wan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0115","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1039\/C4NR03865G","article-title":"Cellular uptake behaviour, photothermal therapy performance, and cytotoxicity of gold nanorods with various coatings","volume":"6","author":"Zhu","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0120","first-page":"8384","article-title":"Surface chemistry of gold nanorods: origin of cell membrane damage and cytotoxicity","volume":"5","author":"Wang","year":"2013","journal-title":"Nano"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0125","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/smll.201000463","article-title":"The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles","volume":"6","author":"Chompoosor","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ar3000647","article-title":"The role of surface functionality in determining nanoparticle cytotoxicity","volume":"46","author":"Kim","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0140","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2567.1996.465550.x","article-title":"Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine","volume":"87","author":"Wilson","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1645\/GE-3186.1","article-title":"Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines","volume":"99","author":"El Ridi","year":"2013","journal-title":"J. Parasitol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2014.00119","article-title":"Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases","volume":"5","author":"El Ridi","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085401","article-title":"Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity","volume":"9","author":"El Ridi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/vaccines3040930","article-title":"From antigen delivery system to adjuvanticy: the board application of nanoparticles in vaccinology","volume":"3","author":"Boraschi","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2018.02.004_bb0175","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/IAI.72.9.5331-5339.2004","article-title":"Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect","volume":"72","author":"Pouniotis","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0180","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1128\/IAI.69.8.5173-5176.2001","article-title":"Dendritic cells can initiate protective immune responses against malaria","volume":"69","author":"Bruna-Romero","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0185","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/acs.bioconjchem.5b00103","article-title":"Guiding principles in the design of molecular bioconjugates for vaccine applications","volume":"26","author":"Liu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.addr.2011.05.016","article-title":"Targeting the lymphatics using dendritic polymers (dendrimers)","volume":"63","author":"Kaminskas","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0195","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/ja2108905","article-title":"Nanoparticle hydrophobicity dictates immune response","volume":"134","author":"Moyano","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mt.2012.185","article-title":"The possible \u201cproton sponge\u201d effect of polyethylenimine (PEI) does not include change in lysosomal pH","volume":"21","author":"Benjaminsen","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0225","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0230","doi-asserted-by":"crossref","first-page":"20459","DOI":"10.1073\/pnas.1010337107","article-title":"Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses","volume":"107","author":"Ritter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0240","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0245","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","article-title":"Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release","volume":"178","author":"Li","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.576","article-title":"The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine","volume":"6","author":"Baron","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0255","doi-asserted-by":"crossref","first-page":"19449","DOI":"10.1073\/pnas.1008155107","article-title":"Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta","volume":"107","author":"Yazdi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.02.004_bb0260","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.biomaterials.2011.11.063","article-title":"Activation of inflammasomes by tumor cell death mediated by gold nanoshells","volume":"33","author":"Nguyen","year":"2012","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918300646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918300646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:34:28Z","timestamp":1759160068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918300646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":52,"alternative-id":["S0168365918300646"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.02.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of gold nanorods as a new vaccine platform against schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}